Technical Assistance in Support of Clinical Training and Mentoring for HIV Treatment | CDC RFA GH13 132905CONT17

Opportunity Information: Apply for CDC RFA GH13 132905CONT17

This funding opportunity, titled "Technical Assistance in Support of Clinical Training and Mentoring for HIV Treatment," is a continuation cooperative agreement issued by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), specifically under CDCs Center for Global Health (CGH). The program is focused on strengthening HIV treatment services by providing technical assistance that supports clinical training and structured mentoring for health care workers involved in HIV care. In practical terms, the opportunity is aimed at improving the quality and consistency of HIV treatment delivery by building the skills of clinicians and health teams, reinforcing evidence-based practices, and supporting ongoing performance improvement through mentoring relationships rather than one-time trainings alone.

The funding mechanism is a cooperative agreement, which generally means the CDC expects to have substantial involvement in the work beyond simply issuing funds. Under a cooperative agreement model, recipients typically coordinate closely with CDC staff on technical direction, implementation approaches, monitoring and evaluation expectations, and alignment with CDC program priorities. Because this is labeled as "Continuation" funding, it is intended to extend or continue an existing program of work rather than launch a brand-new initiative from scratch. That usually implies that applicants are expected to already have relevant infrastructure, partnerships, and experience delivering training and mentoring support in HIV treatment settings, and that the continuation will help sustain and refine those efforts.

The opportunity is identified by Funding Opportunity Number "CDC RFA GH13-132905CONT17" and is categorized under the broader activity area of Health. The associated CFDA number is 93.067, which is commonly tied to CDC global health and HIV-related programming. While the summary information provided does not list a specific award ceiling (shown as 0), it does state an expectation of 10 awards, suggesting that CDC planned to support multiple recipients to cover different geographies, networks, or technical areas related to HIV clinical capacity building. The absence of a ceiling in the summary data often reflects that the exact funding level may vary by recipient, scope, or availability of appropriations, or that it is specified elsewhere in the full announcement package rather than in this excerpt.

Eligibility is listed as "Others," with a note to consult an "Additional Information on Eligibility" section for clarification. In CDC grant language, "Others" can include a range of non-federal entities such as non-profits, universities, research organizations, professional associations, and other qualified institutions, sometimes including international organizations depending on program rules. The key takeaway from the eligibility line is that applicants would need to confirm eligibility in the full announcement text, since the category is intentionally broad and may include specific limitations or required characteristics (for example, demonstrated experience with HIV clinical training platforms, existing presence in supported countries, or prior involvement in the underlying project being continued).

The timeline shown indicates the opportunity was created on February 6, 2017, with an original closing date of April 6, 2017. That roughly two-month window is consistent with a competitive continuation process where CDC solicits applications from eligible entities that can quickly demonstrate operational readiness, technical expertise, and the ability to maintain continuity of support to HIV treatment programs. Because HIV clinical training and mentoring are workforce-intensive and often embedded into service delivery sites, continuity matters: a gap in mentoring or clinical support can lead to declines in adherence to protocols, weaker case management, and inconsistent patient outcomes, so continuation awards typically aim to prevent disruption.

Overall, the purpose of the grant is to enhance HIV treatment outcomes by investing in the people and systems delivering care. "Clinical training" in this context generally points to structured instruction on HIV treatment guidelines, antiretroviral therapy management, management of co-infections and comorbidities, laboratory monitoring, patient counseling, retention and adherence strategies, and differentiated service delivery models. "Mentoring" typically refers to longer-term, on-the-job support such as case-based learning, supervisory visits, quality improvement coaching, and targeted problem-solving with facility teams to translate guidelines into consistent practice. By funding organizations that can provide this kind of technical assistance at scale, CDC is supporting a pathway to stronger clinical competence, better treatment quality, and more reliable patient-centered HIV care.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Technical Assistance in Support of Clinical Training and Mentoring for HIV Treatment" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 06, 2017.
• Applicants must submit their applications by Apr 06, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH13 132905CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: